Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1031178Generated: November 1, 2026

Morpholine → 3,4-Dihydro-1,4-dimethyl-2[2-(4-morpholinyl)ethyl]-1H-[1,3,5]triazepino[3,2-a]benzimidazol-5(2H)-one

https://huagongshe.com/reaction/1031178

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMorpholineHCID 8083—
Reactant2-(2-Chloroethyl)-3,4-dihydro-1,4-dimethyl-1H-[1,3,5]triazepino[3,2-a]benzimidazol-5(2H)-oneHCID 19819759—
Product3,4-Dihydro-1,4-dimethyl-2[2-(4-morpholinyl)ethyl]-1H-[1,3,5]triazepino[3,2-a]benzimidazol-5(2H)-oneHCID 19819774—

Reaction Conditions

Temperature60 °C

Reaction Steps

To 3.0 g (0.0103 mol) of 2-(2-chloroethyl)-3,4-dihydro-1,4-dimethyl-1H-[1,3,5]triazepino[3,2-a]benzimidazol-5(2H)-one was added 20 mL of morpholine. The mixture was stirred at 60° C. for 4 hr. The morpholine was removed at 60° C. and approximately 1 mm Hg. The residue was partitioned between 100 mL of CH2Cl2 and 100 mL of 1N NaOH. The basic layer was reextracted with 50 mL of CH2Cl2. The combined organic extracts were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The residue was crystallized from isopropyl alcohol to afford 2.1 g (59%) of white analytically pure crystals, mp 149°-151.5° C.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05109013
Source datasetuspto-grants-1992_04
ORD IDord-75ec29a1399f4ce6998dc52c12adc171
Source noteuspto-grants-1992_04